↗5 Form 4 rows in the window
Covers original filings from Aug 1, 2026 to Oct 29, 2026. Older trades and amendments are in the SEC history.
$0.00Bought on the market
$6.4MSold on the market
1Companies
Oct 2, 2026Latest filing
| Company | Title | Type | Owned | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Oct 2, 202616:40 | Oct 1, 2026 | GILDGILEAD SCIENCES, INC. | Chairman & CEO, Director | S · Sell10b5-1 | $147.90 | −15,000 | 566,683 | -3% | −$2.2M | ||
| Sep 11, 202618:27 | Sep 10, 2026 | GILDGILEAD SCIENCES, INC. | Chairman & CEO, Director | M · Exercise | — | +8,780 | 585,913 | +2% | — | ||
| Sep 11, 202618:27 | Sep 10, 2026 | GILDGILEAD SCIENCES, INC. | Chairman & CEO, Director | F · Tax | $144.81 | −4,230 | 581,683 | -1% | $613K | ||
| Sep 2, 202616:12 | Sep 1, 2026 | GILDGILEAD SCIENCES, INC. | Chairman & CEO, Director | S · Sell10b5-1 | $148.64 | −15,000 | 577,133 | -3% | −$2.2M | ||
| Aug 4, 202617:40 | Aug 3, 2026 | GILDGILEAD SCIENCES, INC. | Chairman & CEO, Director | S · Sell10b5-1 | $130.31 | −15,000 | 592,133 | -2% | −$2.0M |